66104-22-1

66104-22-1 structure
66104-22-1 structure
  • Name: Pergolide
  • Chemical Name: pergolide
  • CAS Number: 66104-22-1
  • Molecular Formula: C19H26N2S
  • Molecular Weight: 314.488
  • Catalog: API Nervous system medication Anti-shock palsy
  • Create Date: 2018-02-18 08:00:00
  • Modify Date: 2026-07-03 21:56:48
  • Pergolide (LY127809 (free base)) is an ergot-derived orally active dopamine receptor agonist. Pergolide can be used for Parkinson disease research[1].

Name pergolide
Synonyms (6aR,9R,10aR)-9-[(methylsulfanyl)methyl]-7-propyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline
Ergoline, 8-((methylthio)methyl)-6-propyl-, (8beta)
8beta-[(Methylthio)methyl]-6-propylergoline
(6aR,9R,10aR)-9-(Methylthiomethyl)-7-propyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline
Ly 141B
Pergolida
PergolideMesylateBase
Permax
PERGOLIDE
LY 141B
66-2 (Mesylate)
8-B-[(METHYLTHIO)METHYL]-6-(PROPIONYL)ERGOLINE
Unii-24mj822nz9
Pergolida [INN-Spanish]
(6aR,9R,10aR)-9-(methylsulfanylmethyl)-7-propyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline
D-6-n-Propyl-8β-methylmercaptomethylergoline
9-((Methylthio)
Pergolide //BP
pergolida
Indolo[4,3-fg]quinoline, ergoline deriv
Permax (TN)
Pergolidum [inn-latin]
(8b)-8-[(Methylthio)methyl]-6-propylergoline
Ergoline, 8-[(methylthio)methyl]-6-propyl-, (8β)
Pergolidum [INN-Latin]
D-6-n-Propyl-8b-methylmercaptomethylergoline
7-propyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline
Ergoline, 8-[(methylthio)methyl]-6-propyl-, (8b)- (9CI)
8β-[(Methylthio)methyl]-6-propylergoline
(6aR,9R,10aR)-9-[(Methylsulfanyl)methyl]-7-propyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]chinolin
Pergolidum
(6,9R)-9-((Methylthio)Methyl)-7-propyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline
Pergolida [inn-spanish]
UNII-24MJ822NZ9
(6,9R)
Pergolide (INN)
D-8b-[(Methylthio)methyl]-6-propylergoline
(8β)-8-[(methylthio)methyl]-6-propylergoline
(8β)-8-[(Methylsulfanyl)methyl]-6-propylergoline
Description Pergolide (LY127809 (free base)) is an ergot-derived orally active dopamine receptor agonist. Pergolide can be used for Parkinson disease research[1].
Related Catalog
References

[1]. Van Camp G, et al. Treatment of Parkinson's disease with pergolide and relation to restrictive valvular heart disease. Lancet. 2004 Apr 10;363(9416):1179-83.

Density 1.1±0.1 g/cm3
Boiling Point 491.3±35.0 °C at 760 mmHg
Melting Point 207.5ºC
Molecular Formula C19H26N2S
Molecular Weight 314.488
Flash Point 250.9±25.9 °C
Exact Mass 314.181671
PSA 44.33000
LogP 4.49
Vapour Pressure 0.0±1.2 mmHg at 25°C
Index of Refraction 1.614
RIDADR UN 1544 6.1/PG II
RTECS KE6344964
Packaging Group II

~%

66104-22-1 structure

66104-22-1

Literature: US4782152 A1, ;

~%

66104-22-1 structure

66104-22-1

Literature: US4166182 A1, ;

~%

66104-22-1 structure

66104-22-1

Literature: Journal of the Chemical Society. Perkin Transactions 1, , # 19 p. 2398 - 2403

~6%

66104-22-1 structure

66104-22-1

Literature: Anastasia; Cighetti; Allevi Journal of the Chemical Society. Perkin Transactions 1, 2001 , # 19 p. 2398 - 2403

~%

66104-22-1 structure

66104-22-1

Literature: Organic Process Research and Development, , vol. 10, # 2 p. 198 - 202

~%

66104-22-1 structure

66104-22-1

Literature: Journal of the Chemical Society. Perkin Transactions 1, , # 19 p. 2398 - 2403
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.